Advertisement

Topics

Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK

06:17 EST 12 Dec 2017 | Labiotech.eu

The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100 available to patients with uveal melanoma before approval.  The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has deemed Immunocore’s technology worth being used by patients before ...

This awesome article Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK

NEXT ARTICLE

More From BioPortfolio on "Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...